Lung Cancer Europe speaking on trust and AI integration at ELF digital health event
Anna Keuchenius, AI and Community Insights Lead at Lung Cancer Europe, speaking about trust and integration in AI-enabled lung cancer care at a European Lung Foundation event.
Lung Cancer Europe speaking on trust and AI integration at ELF digital health event
Lung Cancer Europe will take part in an online event hosted by the European Lung Foundation exploring how digital health tools and artificial intelligence are being integrated into respiratory care.
The conference, “Developing people-centric digital and AI-enabled solutions for respiratory care,” will take place online on 5 March from 13:00–16:00 CET. It will bring together people living with lung cancer, members of the public, healthcare professionals and researchers from across Europe to discuss how digital technologies are changing the way respiratory diseases and cancer are diagnosed, monitored and treated.
Anna Keuchenius, AI and Community Insights Lead at Lung Cancer Europe, will represent us at the event. Her contribution will focus on trust and integration - ensuring AI tools work together within clinical care and remain understandable and useful for people affected by lung cancer.
AI-supported tools are already beginning to influence areas such as diagnostics, treatment decision support, data analysis and remote monitoring in lung cancer care. While these technologies offer significant opportunities to improve outcomes and personalise care, their successful implementation depends on trust, transparency and meaningful patient involvement.
For people affected by lung cancer, questions about how health data is used, how AI systems are integrated into clinical pathways and work together, and whether these innovations improve access to streamlined care across Europe are central to the discussion.
Just as importantly, digital health tools should not overwhelm people with a growing range of separate apps, platforms and AI tools that do not connect with each other or with clinical care. Integration is essential so that technology supports patients rather than adding another layer of complexity.
Lung Cancer Europe represents national member organisations across Europe and works to ensure that lived experience informs research, policy and innovation. As digital health tools continue to evolve, integrating patient perspectives is essential to developing systems that are equitable, understandable and trusted.
The event will also highlight examples of digital and AI-enabled innovation in respiratory conditions such as asthma and COPD, with cancer care presented as an area where these technologies are advancing rapidly.
The conference is free to attend and open to anyone who wishes to join. The European Lung Foundation does not charge for its events or educational materials, although voluntary donations are welcomed to support patient education.